Fig. 3 | British Journal of Cancer

Fig. 3

From: STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer

Fig. 3

STING agonist treatment enhances a TH1 type response in TME. NanoString-based tumour immune transcriptome profiling showing a significantly differentially expressed immune response, b IFN pathway, and c antigen processing and presentation pathway associated genes in ID8-Trp53−/− tumours collected at endpoint from STING agonist (i.p.) and vehicle-treated mice (n = 3 each group)

Back to article page